The story of Viagra presents a intricate picture for investors. While the initial release generated massive returns, the end of its patent opened the floodgates to generic competitors, dramatically eroding revenue. https://prestontows872091.blogsidea.com/48631189/the-copyright-and-pharma-a-risky-opportunity